Literature DB >> 420464

Dimethyltriazenoimidazole carboxamide therapy of malignant glucagonoma.

G M Strauss, S A Weitzman, T T Aoki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 420464     DOI： 10.7326/0003-4819-90-1-57

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Retrobulbar neuritis as the first sign of the glucagonoma syndrome.

Authors:  E R Lambrecht; T L van der Loos; A H van der Eerden
Journal:  Int Ophthalmol       Date:  1987-10       Impact factor: 2.031

2.  Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor.

Authors:  S Del Prato; A Rovira; P Tessari; A Avogaro; R Nosadini; I Valverde; R Trevisan; A Tiengo
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

Review 3.  Response of paraneoplastic syndromes to antineoplastic therapy.

Authors:  M Markman
Journal:  West J Med       Date:  1986-05

Review 4.  Pancreatic glucagonoma with and without syndrome. Immunocytochemical study of 5 tumour cases and review of the literature.

Authors:  E Ruttman; G Klöppel; G Bommer; M Kiehn; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

5.  Glucagonoma and its angiographic diagnosis.

Authors:  A S Wawrukiewicz; J Rösch; F S Keller; D A Lieberman
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.